CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

ResMed Publishes Q1 FY2027 Earnings Call Transcript

By Public Technologies
  • ResMed's Oct. 29, 2026, Q1 fiscal 2027 earnings call featured CEO Michael J. Farrell, CFO Aaron Bloomer and investor-relations chief Sallilyn Schwartz.
  • Quarterly revenue reached $1.4 billion; non-GAAP diluted earnings per share rose 14% to $2.91.
  • Management maintained full-year revenue guidance of $5.75 billion-$5.85 billion; non-GAAP earnings per share remain projected at $12-$12.25.
  • Core constant-currency revenue growth guidance remains 5%-7%, with Bloomer calling the midpoint most likely as France's fleet-renewal benefit fades.
  • Non-GAAP gross margin reached 62.5%; deferred Indiana expansion costs create an expected 30-basis-point sequential headwind in Q2.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk